BioElectronics Announces ActiPatch: Over-The-Counter Alternative to Opioids

FREDERICK, MD, Dec. 12, 2017 (GLOBE NEWSWIRE) — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced wearable consumer pain management medical device, ActiPatch, announced today the launch of ActiPatch for Over-The-Counter, drug-free pain relief as an alternative to Opioids. ActiPatch is approved by the FDA for Over-The-Counter sales for the adjunctive treatment of pain due to: 1) Osteoarthritis of the Knee and 2) Plantar Fasciitis.

The ActiPatch® Musculoskeletal Pain Therapy is a wearable medical device that is FDA cleared for non-prescription use. ActiPatch performed well in its UK retail store, Boots, launch and rose to the number 1 item in their online store,, for pain relief. There is clinical evidence in which ActiPatch users reported:

  • Reduced opioid pain medication use by 33%
  • Reduced other prescription pain medication use by 65%
  • Reduced pain level by 57%
  • Reduced side-effects from overall pain medication usage

Why ActiPatch works when NOTHING else does?

Research shows that your pain persists because your nerves have “learned” pain. When this happens, your body becomes highly sensitive to pain signals, leading to pain that does not go away even after our injury has healed. Drugs and TENS are not effective because they do not target the underlying problem: abnormal pain signals in your nerves.

What is ActiPatch?

ActiPatch safely corrects abnormal pain signaling in your nerves. This advanced therapy reaches deep into the painful area to provide real relief at the source. The ActiPatch can be used 24/7 and has no harmful side effects. Wear an ActiPatch and get pain relief where it matters.

With the current opioid crisis here in the United States the Over-The- Counter wearable device is a viable, first line choice for pain. It allows consumers to make the choice to find a drug-free alternative to treat their pain.

We are quickly adding regional retailers whose customers are asking for and seeking choices other that opioids. ActiPatch is also happy to announce retail distribution in the United States through ANDA, as a national distributor. “We are pleased to get ActiPatch national distribution through ANDA to retailers, it is a HUGE win for us here in the United States and will be a catalyst for growth,” said Keith Nalepka, VP of Sales and Marketing at BioElectronics Corp. Contact your ANDA sales rep at 1-800-331-2632 for more details about ActiPatch. The ANDA items numbers are:

  • #500723 for the 7-Day ActiPatch trial device
  • #500724 for the 30-Day ActiPatch device

About BioElectronics Corporation

BioElectronics Corporation is a leader in non-invasive electroceuticals and the maker of an industry leading family of disposable, drug-free, pain therapy devices: ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative wound care; Allay® Menstrual Pain Therapy. For more information, please visit

Contact: Paul Knopick